Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
  1. 4 Grant or award Director acquired 6,250 shares (grant or award)
  2. 4 Grant or award Director acquired 6,250 shares (grant or award)
  3. 4 Grant or award Director acquired 6,250 shares (grant or award)
  4. 4 Grant or award Director acquired 6,250 shares (grant or award)
  5. 4 Grant or award Director acquired 6,250 shares (grant or award)
  6. 4 Grant or award Director acquired 6,250 shares (grant or award)
  7. 4 Grant or award Director acquired 6,250 shares (grant or award)
  8. 4 Open-market sale EVP, CLO & CPO sold 22,960 shares at an average $36.76 ($844,093)
  9. 4 Open-market sale EVP & Chief Technology Officer sold 10,000 shares at $40.06 ($400,587)
  10. 4 Open-market sale Director sold 14,850 shares at $35.00 ($519,750)
  11. 4 Grant or award EVP & Chief Legal Officer acquired 7,590 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award EVP & Chief Technology Officer acquired 8,170 shares (grant or award)
  14. 4 Grant or award SVP & Controller acquired 8,000 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award See Remarks acquired 10,545 shares (grant or award)
  18. 4 Open-market sale EVP & Chief Legal Officer sold 25,000 shares at $27.26 ($681,380)
  19. 4 Open-market sale President & CEO sold 66,886 shares at $18.28 ($1,222,669)
  20. 4 Derivatives Options or other derivatives

Page 6 of 17 · 326 filings